Electrophysiology
Engineering the extraordinary — collaborating with you to drive innovation and create the future of healthcare.
Cardiac rhythm conditions
Discover a broad portfolio of innovative solutions to help you diagnose, treat, and manage your cardiac patients.
Therapies and procedures
Atrial fibrillation (AF) management
Find out how exclusive innovations across our implantable devices and cardiac ablation portfolios can help you manage patients with or at risk of AF.
Bradyarrhythmia management
Discover a broad portfolio of bradycardia treatments that provides a range of innovative options for more of your patients.
Cardiac ablation
Learn how catheter-based ablation may be used to treat arrhythmias.
Heart failure (HF) management
People are unique. Our cardiac resynchronization therapy (CRT) portfolio of devices is too. Our devices include a variety of comprehensive features to help tailor heart failure therapy for each of your patient's needs.
Tachyarrhythmia management
A defibrillator isn’t just a defibrillator. Learn about our full line of implantable cardioverter defibrillator (ICD) systems for treating your patients with tachyarrhythmias.
Cardiac diagnostics and monitoring
Accuracy matters. Learn how our proven insertable cardiac monitors (ICMs) deliver the data you need to make the right diagnosis for your patients.1
Patient management
Learn about cardiac device solutions that support implant and follow-up and help keep you connected to your patients.
Reduced complications
Discover device-based innovations to reduce complications.
- 63% reduction in major complications with the Micra™ VR transcatheter pacing system2
- 81% reduction in LV lead dislodgements during slitting with Attain Stability™ Quad MRI SureScan™ active fixation LV lead3,4
- 61% reduction in device pocket infections with TYRX™ Absorbable Antibacterial Envelope5
Reduced ER visits/hospitalizations
Learn about exclusive device innovations to reduce ER visits and hospitalizations.
Reduce AF-related ER visits
- 68% fewer with Reactive ATP™ algorithm6
Reduce AF-related hospitalizations
- 42% fewer with Reactive ATP algorithm6
- 58% fewer with AdaptivCRT™ algorithm7
Reduce HF readmissions
- 59% reduction in a patient’s odds of a 30-day readmission with AdaptivCRT algorithm8
- Automatically identify patients at the highest risk of heart failure hospitalization in the next 30 days with TriageHF™ technology, a heart failure risk stratification tool.9
Additional resources
Education
View our education and training materials for more information.
Clinical trials
See the latest clinical data here.
Related pages
Medtronic 24-hour support
Follow us on social media.
Stay up to date on product updates and events.
- Twitter: @MDT_Cardiac
- LinkedIn: Cardiac & Vascular
- YouTube: MedtronicCardiac
- Facebook: Medtronic Heart
References
1
ICM Publications. Medtronic data on file. 2021.
2
El-Chami MF, Al-Samadi F, Clementy N, et al. Updated performance of the Micra transcatheter pacemaker in the real-world setting: A comparison to the investigational study and a transvenous historical control. Heart Rhythm. December 2018;15(12):1800–1807.
3
Crossley GH, Biffi M, Johnson B, et al. Performance of a novel left ventricular lead with short bipolar spacing for cardiac resynchronization therapy: primary results of the Attain Performa quadripolar left ventricular lead study. Heart Rhythm. April 2015;12(4):751–758.
4
Crossley GH, et al. Performance of a Novel Active Fixation Quadripolar Left Ventricular Lead for Cardiac Resynchronization Therapy. Presented at HRS 2019.
5
Tarakji KG, Mittal S, Kennergren C, et al. Antibacterial Envelope to Prevent Cardiac Implantable Device Infection. N Engl J Med. May 16, 2019;380(20):1895–1905.
6
Boriani G, Manolis AS, Tukkie R, et al. Effects of enhanced pacing modalities on health care resource utilization and costs in bradycardia patients: An analysis of the randomized MINERVA trial. Heart Rhythm. June 2015;12(6):1192–1200.
7
Lemke B, et al. Atrial Fibrillation Resource Use with an Adaptive Device Algorithm. Presented at CardioStim 2014.
8
Starling RC, Krum H, Bril S, et al. Impact of a Novel Adaptive Optimization Algorithm on 30-Day Readmissions: Evidence From the Adaptive CRT Trial. JACC Heart Fail. July 2015;3(7):565–572.
9
Cowie MR, Sarkar S, Koehler J, et al. Development and validation of an integrated diagnostic algorithm derived from parameters monitored in implantable devices for identifying patients at risk for heart failure hospitalization in an ambulatory setting. Eur Heart J. August 2013;34(31):2472–2480.